See today's BioWorld MedTech
To read the full story, subscribe or sign in.

FTC gives Boston Scientific a nod for updated divestiture plan

Feb. 24, 2022
By Mark McCarty
The U.S. Federal Trade Commission has signed off on an amendment to the divestiture plan for Boston Scientific Corp. (BSX), of Marlborough, Mass., related to the acquisition of British Technology Group plc (BTG).
BioWorld MedTech Deals and M&A U.S. FTC